Literature DB >> 7962278

Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men.

A Bélanger1, B Candas, A Dupont, L Cusan, P Diamond, J L Gomez, F Labrie.   

Abstract

It is well recognized that aging in men is accompanied by a decline in the serum levels of some adrenal and testicular steroids, but little or no attention has focused on the multiple steroid metabolites that are formed by steroid-converting enzymes in target tissues. In the present study, we have examined in detail the serum concentrations of a large series of adrenal and testicular steroids and their most significant metabolites produced in intracrine peripheral tissues. The serum concentrations of 26 conjugated and unconjugated C21-, C19-, and C18-steroids were measured in 2423 men aged 40-80 yr. The serum concentrations of the major circulating adrenal C19-steroids, namely dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S), androst-5-ene-3 beta, 17 beta-diol and its sulfate, and androstenedione, decreased by about 60% between the ages of 40-80 yr. The small decrease in the serum concentrations of progesterone and pregnenolone in the presence of increased levels of cortisol and markedly decreased levels of DHEA, androst-5-ene-3 beta, 17 beta-diol, and their polar metabolites suggests that adrenal 17,20-lyase is particularly affected by aging. In addition to a marked decline in the serum concentrations of adrenal C19-steroids, a smaller, but significant, decrease occurred in serum testosterone. However, serum dihydrotestosterone levels remained constant, but the glucuronidated derivatives of dihydrotestosterone metabolites (androstane-3 alpha, 17 beta-diol glucuronide, androstane-3 beta, 17 beta-diol glucuronide, and androsterone glucuronide) were reduced by 45-50%, suggesting that 5 alpha-reductase activity in peripheral tissues may show a compensatory increase during aging. Analysis of the fatty acid esters of DHEA (DHEA-FA) also revealed that these nonpolar steroids markedly decrease between 40-80 yr of age, although such a decrease in DHEA-FA levels was smaller than that in DHEA and DHEA-S, suggesting that the formation of DHEA-FA may be specifically increased during aging. In summary, the present study suggests that in contrast to the marked decline in activity of steroidogenic enzymes in the adrenals and the small decrease in the testis, the activity of the steroid-converting enzymes present in peripheral tissues does not decrease during aging. In fact, the marked decrease in DHEA formation by the adrenals leads to a decrease of about 50% in total androgens in men between the ages of 40-80 yr. Such a decrease probably affects many physiological processes during aging.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962278     DOI: 10.1210/jcem.79.4.7962278

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  74 in total

Review 1.  Dehydroepiandrosterone sulfate and longevity: new clues for an old friend.

Authors:  S S Yen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

2.  Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia.

Authors:  Tristan M Nicholson; Kristen S Uchtmann; Conrad D Valdez; Ashleigh B Theberge; Tihomir Miralem; William A Ricke
Journal:  J Vis Exp       Date:  2013-08-28       Impact factor: 1.355

3.  Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.

Authors:  Emily A Ricke; Karin Williams; Yi-Fen Lee; Suzana Couto; Yuzhuo Wang; Simon W Hayward; Gerald R Cunha; William A Ricke
Journal:  Carcinogenesis       Date:  2012-04-25       Impact factor: 4.944

4.  Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women.

Authors:  Irene Lambrinoudaki; George Christodoulakos; Leon Aravantinos; Aristidis Antoniou; Demetrios Rizos; Constantinos Chondros; Apostolos Kountouris; Grigorios Chrysofakis; George Creatsas
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 5.  DHEA as physiological replacement therapy at menopause.

Authors:  F Labrie
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

6.  Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease.

Authors:  Nanthia A Suthana; Allison Krupa; Markus Donix; Alison Burggren; Arne D Ekstrom; Michael Jones; Linda M Ercoli; Karen J Miller; Prabha Siddarth; Gary W Small; Susan Y Bookheimer
Journal:  Neuroimage       Date:  2009-12-18       Impact factor: 6.556

7.  The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission.

Authors:  Thomas G Travison; Rebecca Shackelton; Andre B Araujo; Susan A Hall; Rachel E Williams; Richard V Clark; Amy B O'Donnell; John B McKinlay
Journal:  J Am Geriatr Soc       Date:  2008-05       Impact factor: 5.562

8.  Endocrine-immune-paracrine interactions in prostate cells as targeted by phytomedicines.

Authors:  Nora E Gray; Xunxian Liu; Renee Choi; Marc R Blackman; Julia T Arnold
Journal:  Cancer Prev Res (Phila)       Date:  2009-01-13

9.  Developmental changes in the endocrine stress response in orangutans (Pongo pygmaeus).

Authors:  Rafaela S C Takeshita; Renata S Mendonça; Fred B Bercovitch; Michael A Huffman
Journal:  J Comp Physiol B       Date:  2019-09-23       Impact factor: 2.200

10.  Estradiol and metabolic syndrome in older italian men: The InCHIANTI Study.

Authors:  Marcello Maggio; Fulvio Lauretani; Gian Paolo Ceda; Stefania Bandinelli; Shehzad Basaria; Giuseppe Paolisso; Claudio Giumelli; Michele Luci; Samer S Najjar; E Jeffrey Metter; Giorgio Valenti; Jack Guralnik; Luigi Ferrucci
Journal:  J Androl       Date:  2008-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.